NCT00499642已完成1 期
A Single-Dose, Double-Blind, Crossover, Placebo- and Moxifloxacin (Open-Label)-Controlled Study of the Effects of Lecozotan SR on Cardiac Repolarization in Healthy Adult Subjects
Wyeth is now a wholly owned subsidiary of Pfizer2 个研究点 分布在 1 个国家开始时间: 2007年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 试验地点
- 2
- 主要终点
- To assess the effect of drug administration on QTc interval.
研究概览
简要总结
This is a randomized, double-blind, placebo- and moxifloxacin (open-label)-controlled, 4-period crossover study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Women and men aged 18 to 55 years inclusive.
- •Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG).
排除标准
- •History of any clinically important drug allergy.
- •Positive findings of urine drug screen (eg, amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, and opiates).
结局指标
主要结局
To assess the effect of drug administration on QTc interval.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
撤回
1 期
A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy VolunteersInfections, BacterialNCT01803399GlaxoSmithKline
已完成
1 期
A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) IntervalDyslipidemiasNCT03577275NorthSea Therapeutics B.V.32
已完成
1 期
Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy SubjectsHealthyNCT04019574Cara Therapeutics, Inc.57
已完成
1 期
A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac RepolarizationNormal Healthy SubjectsNCT01941446Tetraphase Pharmaceuticals, Inc.54
已完成
1 期
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy VolunteersDry Eye SyndromeNCT01162954Dong-A ST Co., Ltd.